Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Bullboard Posts
Comment by ValueHunter92on Mar 29, 2016 3:53pm
251 Views
Post# 24708505

RE:My name Dr. Snrub

RE:My name Dr. Snrub

Hi Mister Snrub,

First, I do want to thank  you for yours concerns about my investment

You do have to know that I am specialized in drug and treaments for the company over 20years +. Specialised in analysis for the company,  I think I know what I am speaking about when I judge that this news is key for valuation increasing and eventual takeover bid or Merger and aquisiton, since they are in a very unique niche medically speaking

Finally, I did not say Pfizer or some company will take over to my knowledge, I just mentionned that it is likely that a major bid for it  happens very soon in the next fews day(Like Pfizer or ANY other majors could do) since the test results worth more than 100 millions and the company is undervalued at this point.
 

I might buy 25 000$ tomorow morning, this stock will go to 1$ very shortly, mark my words
 

Dr Shreiber
PhD Pharmaco-Biology

Bullboard Posts